{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:58:03Z","timestamp":1774882683108,"version":"3.50.1"},"reference-count":199,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ccc.2013.03.002","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T04:19:51Z","timestamp":1367986791000},"page":"411-441","source":"Crossref","is-referenced-by-count":29,"title":["Infection in Neutropenic Patients with Cancer"],"prefix":"10.1016","volume":"29","author":[{"given":"Eric J.","family":"Bow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9340","key":"10.1016\/j.ccc.2013.03.002_bib1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","article-title":"Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis","volume":"360","author":"Brenner","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00134-005-2835-6","article-title":"The intensive care support of patients with malignancy: do everything that can be done","volume":"32","author":"Azoulay","year":"2006","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcrc.2011.06.014","article-title":"Critically ill patients with cancer and sepsis: clinical course and prognostic factors","volume":"27","author":"Rosolem","year":"2012","journal-title":"J\u00a0Crit Care"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0959-8049(03)00004-2","article-title":"Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period","volume":"39","author":"Maschmeyer","year":"2003","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib6","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1164\/ajrccm.160.6.9812055","article-title":"Outcomes of critically ill cancer patients in a university hospital setting","volume":"160","author":"Kress","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib7","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc7713","article-title":"Characteristics and outcomes of cancer\u00a0patients in European ICUs","volume":"13","author":"Taccone","year":"2009","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.ccc.2013.03.002_bib8","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/annonc\/mdr520","article-title":"Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre","volume":"23","author":"Schelenz","year":"2012","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ccc.2013.03.002_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.47102\/annals-acadmedsg.V41N7p287","article-title":"Prospective audit of post-chemotherapy febrile neutropenia in patients with solid cancer and lymphoma in two Singaporean cancer centres","volume":"41","author":"Wong","year":"2012","journal-title":"Ann Acad Med Singap"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10245330701384237","article-title":"Predictive factors of septic shock and mortality in neutropenic patients","volume":"12","author":"Ramzi","year":"2007","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0749-0704(05)70208-6","article-title":"Intensive care, mechanical ventilation, dialysis, and cardiopulmonary resuscitation. Implications for the patient with cancer","volume":"17","author":"Groeger","year":"2001","journal-title":"Crit Care Clin"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccc.2009.10.003","article-title":"Admission criteria and prognostication in patients with cancer admitted to the intensive care unit","volume":"26","author":"Shelton","year":"2010","journal-title":"Crit Care Clin"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","article-title":"Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Flowers","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib15","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/1097-0142(197804)41:4<1610::AID-CNCR2820410452>3.0.CO;2-B","article-title":"Fever and infection in leukemic patients: a study of 494 consecutive patients","volume":"41","author":"Bodey","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.ccc.2013.03.002_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archinte.1975.00330050089015","article-title":"Clinical presentation of infection in granulocytopenic patients","volume":"135","author":"Sickles","year":"1975","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccc.2013.03.002_bib17","series-title":"Management of infections in oncology patients","first-page":"71","article-title":"Infectious complications in patients receiving cytotoxic therapy for\u00a0acute leukemia: history, background and approaches to management","author":"Bow","year":"2003"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/137.1.14","article-title":"Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC International Antimicrobial Therapy Project group","volume":"137","author":"Schimpff","year":"1978","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib19","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1200\/JCO.1996.14.2.636","article-title":"Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia","volume":"14","author":"Blay","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bjc.6600724","article-title":"Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy","volume":"88","author":"Ray-Coquard","year":"2003","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.ccc.2013.03.002_bib22","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.leu.2404440","article-title":"Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia","volume":"20","author":"Bow","year":"2006","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib23","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1200\/JCO.1997.15.6.2254","article-title":"Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults","volume":"15","author":"Bow","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cncr.20733","article-title":"Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests","volume":"103","author":"Lutgens","year":"2005","journal-title":"Cancer"},{"issue":"Suppl 9","key":"10.1016\/j.ccc.2013.03.002_bib25","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/cncr.20163","article-title":"Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis","volume":"100","author":"Rubenstein","year":"2004","journal-title":"Cancer"},{"issue":"Suppl 9","key":"10.1016\/j.ccc.2013.03.002_bib26","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00520-003-0572-3","article-title":"Measuring mucosal damage induced by cytotoxic therapy","volume":"12","author":"Blijlevens","year":"2004","journal-title":"Support Care Cancer"},{"issue":"25","key":"10.1016\/j.ccc.2013.03.002_bib28","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for oral mucositis after intensive therapy for hematologic cancers","volume":"351","author":"Spielberger","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccc.2013.03.002_bib29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2007.13.6028","article-title":"Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy\u2013European Blood and Marrow Transplantation Mucositis Advisory Group","volume":"26","author":"Blijlevens","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2141.2000.02202.x","article-title":"Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue","volume":"110","author":"Wardley","year":"2000","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib31","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1200\/JCO.2003.10.079","article-title":"Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant","volume":"21","author":"Meropol","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.seminhematol.2009.03.002","article-title":"Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes","volume":"46","author":"Bow","year":"2009","journal-title":"Semin Hematol"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.bmt.1705118","article-title":"Inflammatory response to mucosal barrier\u00a0injury after myeloablative therapy in allogeneic stem cell transplant recipients","volume":"36","author":"Blijlevens","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/bmt.2008.270","article-title":"Febrile mucositis in haematopoietic SCT recipients","volume":"43","author":"van der Velden","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.soncn.2003.10.003","article-title":"Pathobiology of mucositis","volume":"20","author":"Sonis","year":"2004","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ncponc0104","article-title":"Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?","volume":"2","author":"Sonis","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","year":"1992","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib38","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society\u00a0of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jama.1995.03520260039030","article-title":"The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study","volume":"273","author":"Rangel-Frausto","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00134-002-1560-7","article-title":"Neutropenia and the development of the systemic inflammatory response syndrome","volume":"29","author":"Regazzoni","year":"2003","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.ccc.2013.03.002_bib41","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0959-8049(97)00042-7","article-title":"Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures","volume":"33","author":"Blot","year":"1997","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00003246-198608000-00006","article-title":"Stratification of prognosis in granulocytopenic patients with hematologic malignancies using the APACHE-II severity of illness score","volume":"14","author":"Johnson","year":"1986","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccc.2013.03.002_bib43","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s001340050996","article-title":"Hematopoietic colony-stimulating factors for neutropenic patients in the ICU","volume":"25","author":"Bouchama","year":"1999","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00365540802454706","article-title":"Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome","volume":"41","author":"Hamalainen","year":"2009","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/01.CCM.0000157752.26180.F1","article-title":"Predictors of intensive care unit refusal in French intensive care units: a multiple-center study","volume":"33","author":"Garrouste-Orgeas","year":"2005","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.ccc.2013.03.002_bib46","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00134-002-1528-7","article-title":"Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients","volume":"28","author":"Darmon","year":"2002","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.ccc.2013.03.002_bib47","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00520-004-0667-5","article-title":"Cancer patients with septic shock: mortality predictors and neutropenia","volume":"12","author":"Regazzoni","year":"2004","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","article-title":"Survival in neutropenic patients with severe sepsis or septic shock","volume":"40","author":"Legrand","year":"2012","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib49","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/sj.leu.2403270","article-title":"Incidence and prognostic value of respiratory events in acute leukemia","volume":"18","author":"Chaoui","year":"2004","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ccc.2009.09.001","article-title":"Critical care of the hematopoietic stem cell transplant recipient","volume":"26","author":"Afessa","year":"2010","journal-title":"Crit Care Clin"},{"issue":"11","key":"10.1016\/j.ccc.2013.03.002_bib51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.bmt.1705502","article-title":"Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit","volume":"38","author":"Naeem","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/bmt.2008.336","article-title":"Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit","volume":"43","author":"Trinkaus","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.bmt.1705222","article-title":"Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter?","volume":"37","author":"Naeem","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib54","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/CCM.0b013e318170efd3","article-title":"Occurrence and outcome of fever\u00a0in critically ill adults","volume":"36","author":"Laupland","year":"2008","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0891-5520(05)70284-1","article-title":"The clinical significance of fever patterns","volume":"10","author":"Cunha","year":"1996","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2796.1999.00539.x","article-title":"Aetiology of fever in patients with acute stroke","volume":"246","author":"Georgilis","year":"1999","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ccc.2013.03.002_bib57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1086\/514520","article-title":"Concepts of fever: recent advances and lingering dogma","volume":"35","author":"Mackowiak","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccc.2013.03.002_bib58","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/jama.1992.03490120092034","article-title":"A\u00a0critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich","volume":"268","author":"Mackowiak","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2013.03.002_bib59","series-title":"Das Verhalten der Eigenwaerme in Krankheiten","author":"Wunderlich","year":"1868"},{"issue":"114","key":"10.1016\/j.ccc.2013.03.002_bib60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000441-186904000-00021","article-title":"The course of the temperature in diseases: a guide to clinical thermometry","volume":"57","author":"Wunderlich","year":"1869","journal-title":"Am J Med Sci"},{"issue":"18","key":"10.1016\/j.ccc.2013.03.002_bib61","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jama.1950.62920180006007","article-title":"Oral and rectal temperatures of man","volume":"144","author":"Horvath","year":"1950","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2013.03.002_bib62","series-title":"Medical thermometry and human temperature","author":"Wunderlich","year":"1871"},{"issue":"9","key":"10.1016\/j.ccc.2013.03.002_bib63","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00007611-199509000-00009","article-title":"Physicians' perceptions regarding body temperature in health and disease","volume":"88","author":"Mackowiak","year":"1995","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1081\/CBI-120037799","article-title":"Thermoregulation during mild exercise at different circadian times","volume":"21","author":"Waterhouse","year":"2004","journal-title":"Chronobiol Int"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib65","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/CCM.0b013e318169eda9","article-title":"Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America","volume":"36","author":"O'Grady","year":"2008","journal-title":"Crit Care Med"},{"issue":"Suppl 2","key":"10.1016\/j.ccc.2013.03.002_bib66","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1007\/s00277-003-0764-4","volume":"82","author":"Link","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ccc.2013.03.002_bib67","unstructured":"Freifeld AG, Segal BH, Baden LR, et\u00a0al. Prevention and treatment of cancer-related infections. 2007. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/infections.pdf. Accessed January, 2013."},{"issue":"Suppl 2","key":"10.1016\/j.ccc.2013.03.002_bib68","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.ijantimicag.2005.08.007","article-title":"Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever","volume":"26","author":"Jun","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 2","key":"10.1016\/j.ccc.2013.03.002_bib69","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijantimicag.2005.08.001","article-title":"Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group","volume":"26","author":"Tamura","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 2","key":"10.1016\/j.ccc.2013.03.002_bib70","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.4067\/S0716-10182005000500001","article-title":"Consensus: rational approach towards the patient with cancer, fever and neutropenia","volume":"22","author":"Santolaya","year":"2005","journal-title":"Rev Chilena Infectol"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib71","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4037\/ajcc1995.4.4.286","article-title":"A\u00a0comparison of five methods of temperature measurement in febrile intensive care patients","volume":"4","author":"Schmitz","year":"1995","journal-title":"Am J Crit Care"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib72","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00134-002-1619-5","article-title":"Temperature measurement in intensive care patients: comparison of urinary bladder, oesophageal, rectal, axillary, and inguinal methods versus pulmonary artery core method","volume":"29","author":"Lefrant","year":"2003","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib73","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2702.2004.00916.x","article-title":"Temperature measurement: comparison of non-invasive methods used in adult critical care","volume":"14","author":"Farnell","year":"2005","journal-title":"J\u00a0Clin Nurs"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1547-5069.1996.tb01173.x","article-title":"Accuracy of chemical dot thermometers in critically ill adults and young children","volume":"28","author":"Erickson","year":"1996","journal-title":"Image J Nurs Sch"},{"issue":"12","key":"10.1016\/j.ccc.2013.03.002_bib75","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1086\/588290","article-title":"The influence of mucositis on oral thermometry: when fever may not reflect infection","volume":"46","author":"Ciuraru","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib76","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0964-3397(97)80425-9","article-title":"Core body temperature measurement: a comparison of axilla, tympanic membrane and pulmonary artery blood temperature","volume":"13","author":"Fulbrook","year":"1997","journal-title":"Intensive Crit Care Nurs"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib77","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1378\/chest.115.4.1002","article-title":"Accuracy of an infrared tympanic thermometer","volume":"115","author":"Amoateng-Adjepong","year":"1999","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.ccc.2013.03.002_bib78","first-page":"783","article-title":"Alternatives to mercury thermometers","volume":"12","author":"O'Toole","year":"1997","journal-title":"Prof Nurse"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00006247-200106000-00023","article-title":"Tympanic membrane vs. pulmonary artery thermometry","volume":"32","author":"Fisk","year":"2001","journal-title":"Nurs Manag"},{"issue":"9","key":"10.1016\/j.ccc.2013.03.002_bib80","first-page":"43","article-title":"Using a tympanic thermometer","volume":"97","author":"Jevon","year":"2001","journal-title":"Nurs Times"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1553-2712.1995.tb03072.x","article-title":"Cerumen occlusion lowers infrared tympanic membrane temperature measurement","volume":"2","author":"Doezema","year":"1995","journal-title":"Acad Emerg Med"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib82","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejon.2009.03.006","article-title":"A\u00a0comparison between infrared tympanic thermometry, oral and axilla with rectal thermometry in neutropenic adults","volume":"13","author":"Dzarr","year":"2009","journal-title":"Eur J Oncol\u00a0Nurs"},{"issue":"Suppl 7","key":"10.1016\/j.ccc.2013.03.002_bib83","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1097\/CCM.0b013e3181aa6117","article-title":"Fever in the critically ill medical patient","volume":"37","author":"Laupland","year":"2009","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccc.2013.03.002_bib84","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s001340050925","article-title":"Fever in the intensive care unit","volume":"25","author":"Cunha","year":"1999","journal-title":"Intensive Care Med"},{"issue":"25","key":"10.1016\/j.ccc.2013.03.002_bib85","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra011089","article-title":"Heat stroke","volume":"346","author":"Bouchama","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib86","first-page":"79","article-title":"The neuroleptic malignant syndrome","volume":"41","author":"Caroff","year":"1980","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"9134","key":"10.1016\/j.ccc.2013.03.002_bib87","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(98)03078-5","article-title":"Malignant hyperthermia","volume":"352","author":"Denborough","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib88","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005792-200007000-00001","article-title":"Serotonin syndrome. Presentation of 2 cases and review of the literature","volume":"79","author":"Mason","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.ccc.2013.03.002_bib89","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1470-2045(05)70346-6","article-title":"Fever of unknown origin and cancer:\u00a0a population-based study","volume":"6","author":"Sorensen","year":"2005","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ccc.2013.03.002_bib90","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/archinte.1979.03630480015009","article-title":"Fever patterns. Their lack of clinical significance","volume":"139","author":"Musher","year":"1979","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib91","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.1981.03310330041024","article-title":"Drug fever","volume":"245","author":"Lipsky","year":"1981","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib92","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1592\/phco.30.1.57","article-title":"Drug fever","volume":"30","author":"Patel","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0891-5520(05)70287-7","article-title":"Drug fever","volume":"10","author":"Johnson","year":"1996","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib94","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-106-5-728","article-title":"Drug fever: a critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature","volume":"106","author":"Mackowiak","year":"1987","journal-title":"Ann Intern Med"},{"issue":"Suppl 5","key":"10.1016\/j.ccc.2013.03.002_bib95","doi-asserted-by":"crossref","first-page":"v252","DOI":"10.1093\/annonc\/mdq196","article-title":"Management of febrile neutropenia: ESMO Clinical Practice Guidelines","volume":"21","author":"de Naurois","year":"2010","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib96","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00277-012-1456-8","article-title":"Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation\u2013guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"91","author":"Weissinger","year":"2012","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.ccc.2013.03.002_bib98","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib99","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ccc.2013.03.002_bib100","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia","volume":"340","author":"Walsh","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib101","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever","volume":"346","author":"Walsh","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.ccc.2013.03.002_bib102","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/426815","article-title":"A\u00a0European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer","volume":"40","author":"Akova","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib104","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3747\/co.v18i6.841","article-title":"Assessment and management of febrile neutropenia in emergency departments within a regional health authority-a benchmark analysis","volume":"18","author":"Szwajcer","year":"2011","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib106","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.bjc.6606059","article-title":"A\u00a0prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG\/NCEPOD findings","volume":"104","author":"Okera","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib107","first-page":"103","article-title":"Effect of a quality improvement intervention to decrease delays in antibiotic delivery in pediatric febrile neutropenia: a pilot study","volume":"26","author":"Amado","year":"2010","journal-title":"J\u00a0Crit Care"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib108","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1634\/theoncologist.12-8-1019","article-title":"Cancer-associated neutropenic fever:\u00a0clinical outcome and economic costs of emergency department care","volume":"12","author":"Courtney","year":"2007","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib109","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1188\/04.ONF.711-715","article-title":"Emergency department waiting times for patients with cancer with febrile neutropenia: a pilot study","volume":"31","author":"Nirenberg","year":"2004","journal-title":"Oncol Nurs Forum"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2141.2008.07481.x","article-title":"Improving management of neutropenic sepsis in the emergency department","volume":"144","author":"Richardson","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib111","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib112","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QCO.0b013e32834cf054","article-title":"Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients","volume":"24","author":"Bow","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib113","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","article-title":"Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock","volume":"136","author":"Kumar","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib114","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijantimicag.2012.05.001","article-title":"Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients","volume":"40","author":"Ram","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.ccc.2013.03.002_bib115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1473-3099(07)70235-9","article-title":"Intravascular catheter-related infections: advances in diagnosis, prevention, and management","volume":"7","author":"Raad","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ccc.2013.03.002_bib116","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00277-006-0096-2","article-title":"Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"85","author":"Penack","year":"2006","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib117","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0b013e3181e96b91","article-title":"A\u00a0survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic\/meta-regression study","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccc.2013.03.002_bib118","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","article-title":"Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccc.2013.03.002_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005197.pub3","article-title":"Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams","author":"Paul","year":"2010","journal-title":"Cochrane\u00a0Database Syst Rev"},{"issue":"10","key":"10.1016\/j.ccc.2013.03.002_bib120","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-120-10-199405150-00004","article-title":"Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer","volume":"120","author":"De Pauw","year":"1994","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib121","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/AAC.39.2.445","volume":"39","author":"Cometta","year":"1995","journal-title":"Antimicrobial Agents Chemother"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib122","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-137-2-200207160-00005","article-title":"Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial","volume":"137","author":"Peacock","year":"2002","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.ccc.2013.03.002_bib123","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1200\/JCO.2000.18.21.3690","article-title":"Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial","volume":"18","author":"Feld","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib124","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/505393","article-title":"A\u00a0randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime\u00a0for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies","volume":"43","author":"Bow","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib125","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.40.5.1108","article-title":"Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for fever\u00a0in granulocytopenic patients with cancer","volume":"40","author":"Cometta","year":"1996","journal-title":"Antimicrobial Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.ccc.2013.03.002_bib126","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/BF01644231","article-title":"Superinfections during antimicrobial treatment with betalactam-aminoglycoside combinations in neutropenic patients with hematologic malignancies","volume":"13","author":"Serra","year":"1985","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib127","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/clind\/24.4.575","article-title":"Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer","volume":"24","author":"Nucci","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib128","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jac\/dks512","article-title":"There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy","volume":"68","author":"Bow","year":"2013","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib129","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejcsup.2007.06.005","article-title":"Empirical antifungal therapy in neutropaenic cancer patients with persistent fever","volume":"5","author":"Marchetti","year":"2007","journal-title":"European Journal of Cancer Supplements"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1444-0903.2004.00541.x","article-title":"Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections","volume":"34","author":"Slavin","year":"2004","journal-title":"Intern Med J"},{"issue":"Suppl 1","key":"10.1016\/j.ccc.2013.03.002_bib131","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/383044","article-title":"Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey","volume":"39","author":"Yoshida","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib132","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijantimicag.2011.11.017","article-title":"Invasive fungal infections in patients with cancer in the intensive care unit","volume":"39","author":"Sipsas","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib133","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A\u00a0bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Leon","year":"2006","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib134","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting","volume":"26","author":"Ostrosky-Zeichner","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1439-0507.2009.01756.x","article-title":"Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit","volume":"54","author":"Ostrosky-Zeichner","year":"2009","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib136","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib137","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1155\/2010\/357076","article-title":"Canadian clinical practice guidelines for invasive candidiasis in adults","volume":"21","author":"Bow","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib138","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jhin.2004.01.006","article-title":"Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence","volume":"56","author":"Vandewoude","year":"2004","journal-title":"J\u00a0Hosp Infect"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib139","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","article-title":"Invasive aspergillosis in the intensive care unit","volume":"45","author":"Meersseman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib140","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4065\/75.6.562","article-title":"Comparison of premortem clinical diagnoses in critically ill patients and subsequent autopsy findings","volume":"75","author":"Roosen","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.ccc.2013.03.002_bib141","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1086\/657065","article-title":"Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib142","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1086\/509931","article-title":"Medical imaging and timely diagnosis of invasive pulmonary aspergillosis","volume":"44","author":"Vandewoude","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib143","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ccc.2013.03.002_bib144","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/JCM.00879-11","article-title":"Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study","volume":"49","author":"De Vlieger","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib145","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/CDLI.10.5.882-885.2003","article-title":"Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients","volume":"10","author":"Digby","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11","key":"10.1016\/j.ccc.2013.03.002_bib146","first-page":"950","article-title":"Fungal infections in ICU patients: epidemiology and the role of diagnostics","volume":"76","author":"Morace","year":"2010","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib147","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccc.2013.03.002_bib148","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib149","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00277-006-0204-3","article-title":"Usefulness of the MSG\/IFICG\/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates","volume":"86","author":"Borlenghi","year":"2007","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3324\/haematol.2012.061952","article-title":"The role of antifungal treatment in hematology","volume":"97","author":"Maertens","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib151","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejcsup.2007.06.007","article-title":"Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients","volume":"5","author":"Herbrecht","year":"2007","journal-title":"European Journal\u00a0of Cancer Supplements"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib152","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccc.2013.03.002_bib153","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients:\u00a0summary of the ECIL 3-2009 Update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ccc.2013.03.002_bib154","volume":"vol. 18","author":"Marr","year":"2012"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib155","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1086\/605665","article-title":"Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)","volume":"49","author":"Girmenia","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib156","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejcsup.2007.06.006","article-title":"Primary antifungal prophylaxis in leukaemia patients","volume":"5","author":"Maertens","year":"2007","journal-title":"European Journal of Cancer Supplements"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib157","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3324\/haematol.11665","article-title":"Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology","volume":"94","author":"Cornely","year":"2009","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"10.1016\/j.ccc.2013.03.002_bib158","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib159","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11046-009-9196-6","article-title":"Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint","volume":"168","author":"Bow","year":"2009","journal-title":"Mycopathologia"},{"issue":"15","key":"10.1016\/j.ccc.2013.03.002_bib160","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.ejca.2008.07.008","article-title":"The First European Conference on Infections in Leukaemia - ECIL1: a current perspective","volume":"44","author":"Meunier","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ccc.2013.03.002_bib161","unstructured":"Baden LR, Bensinger W, Angarone M, et\u00a0al. Prevention and treatment of cancer-related infections. National Clinical Practice Guidelines in Oncology (NCCN Guidelines)\u00a02012; version 1.2012. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/infections.pdf. Accessed January 19, 2013."},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib162","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jac\/37.5.975","article-title":"A\u00a0meta-analysis of clinical studies of imipenem-cilastatin for empirically treating febrile neutropenic patients","volume":"37","author":"Deaney","year":"1996","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib163","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/42.4.511","article-title":"Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer)","volume":"42","author":"Biron","year":"1998","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib164","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7883\/yoken.65.228","article-title":"A\u00a0comparative analysis of meropenem and doripenem in febrile patients with hematologic malignancies: a single-center retrospective study","volume":"65","author":"Toya","year":"2012","journal-title":"Jpn J Infect Dis"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib165","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.coph.2012.06.003","article-title":"Improving known classes of antibiotics: an optimistic approach for the future","volume":"12","author":"Bush","year":"2012","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib166","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s005200000105","article-title":"Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis","volume":"8","author":"Furno","year":"2000","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.ccc.2013.03.002_bib167","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1473-3099(05)70164-X","article-title":"Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials","volume":"5","author":"Vardakas","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib168","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.mayocp.2011.12.011","article-title":"Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design","volume":"87","author":"Vardakas","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib169","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/10428194.2011.602770","article-title":"Management of gram-positive bacterial infections in patients with cancer","volume":"53","author":"Kosmidis","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.ccc.2013.03.002_bib170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/500139","article-title":"Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer","volume":"42","author":"Jaksic","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ccc.2013.03.002_bib171","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4065\/80.9.1146","article-title":"Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials","volume":"80","author":"Bliziotis","year":"2005","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.ccc.2013.03.002_bib172","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccc.2013.03.002_bib173","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1086\/599226","article-title":"Nephrotoxicity of colistin: new insight into an old antibiotic","volume":"48","author":"Falagas","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib174","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/jac\/39.6.677","article-title":"Once-daily dosing of aminoglycosides: review and recommendations for clinical practice","volume":"39","author":"Freeman","year":"1997","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib175","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/jac\/dkq451","article-title":"Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and meta-analysis","volume":"66","author":"Mavros","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ccc.2013.03.002_bib176","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1749-6632.2011.06330.x","article-title":"The oxazolidinones: past, present, and future","volume":"1241","author":"Shaw","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 5","key":"10.1016\/j.ccc.2013.03.002_bib177","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1086\/431672","article-title":"Tigecycline: a new glycylcycline for treatment of serious infections","volume":"41","author":"Noskin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib178","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1371\/journal.ppat.0040035","article-title":"Mucosal damage and neutropenia are required for Candida albicans dissemination","volume":"4","author":"Koh","year":"2008","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib179","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ccc.2013.03.002_bib180","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cncr.22909","article-title":"Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation","volume":"110","author":"Kontoyiannis","year":"2007","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.ccc.2013.03.002_bib181","first-page":"1","article-title":"Invasive fungal infection in patients receiving intensive cytotoxic therapy\u00a0for cancer","volume":"101","author":"Bow","year":"1998","journal-title":"Br J Haematol"},{"issue":"Suppl D","key":"10.1016\/j.ccc.2013.03.002_bib182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/41.suppl_4.1","article-title":"Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies","volume":"41","author":"Bow","year":"1998","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ccc.2013.03.002_bib183","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2141.2002.03394.x","article-title":"Impaired gut function as risk factor for invasive candidiasis in neutropenic patients","volume":"117","author":"Blijlevens","year":"2002","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.ccc.2013.03.002_bib184","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/01.CCM.0000201897.78123.44","article-title":"Invasive candidiasis in the intensive care unit","volume":"34","author":"Ostrosky-Zeichner","year":"2006","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccc.2013.03.002_bib185","first-page":"681","article-title":"Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole","volume":"49","author":"Michallet","year":"2011","journal-title":"Med Mycol"},{"issue":"24","key":"10.1016\/j.ccc.2013.03.002_bib186","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1182\/blood-2010-04-279307","article-title":"Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity","volume":"116","author":"Cunha","year":"2010","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.ccc.2013.03.002_bib187","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMoa0802629","article-title":"Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation","volume":"359","author":"Bochud","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ccc.2013.03.002_bib188","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bmt.1705181","article-title":"Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation","volume":"36","author":"Seo","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib189","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","article-title":"Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation","volume":"47","author":"Garcia-Vidal","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccc.2013.03.002_bib190","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1086\/652761","article-title":"Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation","volume":"50","author":"Panackal","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccc.2013.03.002_bib191","series-title":"Managing infections in patients with hematological malignancies","first-page":"259","article-title":"Prophylaxis","author":"Bow","year":"2009"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib192","first-page":"257","article-title":"Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters","volume":"66","author":"Oren","year":"2001","journal-title":"Am Jew Hist"},{"issue":"7","key":"10.1016\/j.ccc.2013.03.002_bib193","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1086\/501661","article-title":"Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation","volume":"20","author":"Cornet","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.ccc.2013.03.002_bib194","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","article-title":"Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008)","volume":"55","author":"Tortorano","year":"2012","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.ccc.2013.03.002_bib195","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.leu.2403674","article-title":"Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies","volume":"19","author":"Muhlemann","year":"2005","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.ccc.2013.03.002_bib196","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/jac\/dks155","article-title":"European Organization for the Research and Treatment of Cancer\/Mycoses Study Group (EORTC\/MSG) host factors and invasive fungal infections in patients with haematological malignancies","volume":"67","author":"Hoenigl","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl\u00a01","key":"10.1016\/j.ccc.2013.03.002_bib197","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1080\/13693780400020113","article-title":"Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results\u00a0of a prospective multicenter surveillance program","volume":"43","author":"Morgan","year":"2005","journal-title":"Med Mycol"},{"issue":"9","key":"10.1016\/j.ccc.2013.03.002_bib198","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/bbmt.2002.v8.pm12374456","article-title":"Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study","volume":"8","author":"Junghanss","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.ccc.2013.03.002_bib199","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/bmt.2010.38","article-title":"Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT","volume":"45","author":"Blennow","year":"2010","journal-title":"Bone Marrow Transplant"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070413000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070413000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T15:31:23Z","timestamp":1688225483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070413000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":199,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0749070413000195"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2013.03.002","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}